FTC, diet pill marketers settle for $25M

Jan 05, 2007

The U.S. Federal Trade Commission recovered $25 million as a settlement in its cases alleging deceptive advertising against marketers of four diet pills.

The FTC filed separate cases against the marketers, alleging that claims about weight loss and weight control were not supported by scientific evidence. In settling the matters, marketers of Xenadrine EFX, CortiSlim, TrimSpa, and One-A-Day WeightSmart surrendered cash and other assets worth at least $25 million and agreed to limit their future advertised claims, the agency said in a news release.

"You won't find weight loss in a bottle of pills that claims it has the latest scientific breakthrough or miracle ingredient," said FTC Chairman Deborah Platt Majoras. "Paying for fad science is a good way to lose cash, not pounds."

Besides fines and penalties, the settlements also stipulated that the marketers are barred from making claims regarding the products' benefits unless the claims can be substantiated by scientific evidence.

The FTC said the National Advertising Division of the Council of Better Business Bureaus referred some of these cases.

Copyright 2007 by United Press International

Explore further: New research demonstrates benefits of national and international device registries

add to favorites email to friend print save as pdf

Related Stories

US online child privacy get stricter

Jul 01, 2013

Toughened US regulations on online privacy for children take effect Monday, offering new protections amid the growing use of mobile apps and social networks by youngsters.

Microsoft renews plea for crackdown on Google

Jan 02, 2013

Microsoft began the new year harping on a favorite theme: The software maker is arguing that government regulators need to crack down on Google to preserve fair competition in the Internet and smartphone markets.

Google faces moment of truth on monopoly probe

Oct 21, 2012

Google faces a moment of truth in the coming weeks over a lengthy US probe into potential abuse of its Internet search dominance, amid regulatory woes on both sides of the Atlantic.

Recommended for you

New approach to particle therapy dosimetry

Dec 19, 2014

Researchers at the National Physical Laboratory (NPL), in collaboration with EMRP partners, are working towards a universal approach to particle beam therapy dosimetry.

Supplement maker admits lying about ingredients

Dec 17, 2014

Federal prosecutors say the owner and president of a dietary supplement company has admitted his role in the sale of diluted and adulterated dietary ingredients and supplements sold by his company.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.